Company intelligence / Profile preview

ITOCHU

Ownership: Private
Employees: ~125000
Development stage: Other

Overview

ITOCHU is one of Japan’s largest general trading companies with significant activities in the life sciences sector through its subsidiary ITOCHU CHEMICAL FRONTIER Corporation. It supplies pharmaceutical raw materials, APIs, intermediates for small molecules and biologics, functional food ingredients such as collagen and GABA, invests in health food ingredient companies like Maypro Group LLC, supports regulatory compliance including GMP studies for pharma clients globally, and has invested in regenerative medicine-related products[1][5].

Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Partnerships

Maypro Group LLC (strategic investment)Promethera Biosciences S.A. (investment/collaboration)

Beyond the preview

Go deeper on ITOCHU.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITOCHU.

Explore the full profile